Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007657956> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2007657956 endingPage "726" @default.
- W2007657956 startingPage "726" @default.
- W2007657956 abstract "Rationale: Natural antibodies against neurotoxic amyloid beta 1-42 (Aß42) were detected in IVIG. Accumulation of Aß42 in the brain is a key pathogenic event in Alzheimer's disease (AD). The purpose of this study was to investigate if IVIG preparations can prevent in vitro neurotoxicity induced by Aß42. Methods: Gammagard Liquid, a highly purified IVIG, contains natural antibodies binding to different conformers of Aß. To examine the potential of IVIG to prevent Aß42- induced neurotoxicity we developed and validated an in vitro assay using pheochromocytoma PC-12 cells, and synthetic Aß42. We assessed the fibrillization state of Aß42 preparation by fluorimetric Thioflavine T binding assay, SDS-PAGE and Western Blot. The analysis of cytotoxicity was done by photometric measurement of Lactate Dehydrogenase released into cell supernatants. Results: We found that Aß42 was predominantly oligomeric and induced concentration-dependently cytotoxicity in PC-12 cells. The cytotoxic effect of Aß42 was cell-specific with neuronal cells being most susceptible. Preincubation of Aß42 with monoclonal anti-Aß42 antibodies decreased the Aß42 induced cytotoxicity in PC-12 cells. 6E10, a monoclonal antibody that shows therapeutic effects in murine models of AD, was most effective. A control murine IgG was not effective. Preincubation of Aß42 with IVIG decreased the cytotoxicity by up to 60%. The potency of different lots was comparable. A control human IgG1 antibody had no effect. Conclusions: Our data indicate that natural anti-Aß42 antibodies contained in IVIG are neuroprotective in vitro. Furthermore, different lots of IVIG should contain comparable levels of neuroprotective antibodies which is an important finding for the clinical application of IVIG." @default.
- W2007657956 created "2016-06-24" @default.
- W2007657956 creator A5021245514 @default.
- W2007657956 creator A5045211170 @default.
- W2007657956 creator A5074030410 @default.
- W2007657956 creator A5087620820 @default.
- W2007657956 creator A5091899471 @default.
- W2007657956 date "2009-03-01" @default.
- W2007657956 modified "2023-10-14" @default.
- W2007657956 title "Natural Anti-Amyloid-beta Antibodies in Intravenous Immunoglobulin (IVIG) Preparation Attenuate Amyloid beta-Induced Neurotoxicity in vitro" @default.
- W2007657956 doi "https://doi.org/10.1016/j.jaci.2009.01.013" @default.
- W2007657956 hasPublicationYear "2009" @default.
- W2007657956 type Work @default.
- W2007657956 sameAs 2007657956 @default.
- W2007657956 citedByCount "0" @default.
- W2007657956 crossrefType "journal-article" @default.
- W2007657956 hasAuthorship W2007657956A5021245514 @default.
- W2007657956 hasAuthorship W2007657956A5045211170 @default.
- W2007657956 hasAuthorship W2007657956A5074030410 @default.
- W2007657956 hasAuthorship W2007657956A5087620820 @default.
- W2007657956 hasAuthorship W2007657956A5091899471 @default.
- W2007657956 hasBestOaLocation W20076579561 @default.
- W2007657956 hasConcept C109316439 @default.
- W2007657956 hasConcept C153911025 @default.
- W2007657956 hasConcept C154317977 @default.
- W2007657956 hasConcept C159654299 @default.
- W2007657956 hasConcept C178790620 @default.
- W2007657956 hasConcept C181199279 @default.
- W2007657956 hasConcept C185592680 @default.
- W2007657956 hasConcept C202751555 @default.
- W2007657956 hasConcept C203014093 @default.
- W2007657956 hasConcept C2777318727 @default.
- W2007657956 hasConcept C2779491297 @default.
- W2007657956 hasConcept C2780783641 @default.
- W2007657956 hasConcept C29730261 @default.
- W2007657956 hasConcept C542903549 @default.
- W2007657956 hasConcept C55493867 @default.
- W2007657956 hasConcept C86803240 @default.
- W2007657956 hasConcept C98274493 @default.
- W2007657956 hasConceptScore W2007657956C109316439 @default.
- W2007657956 hasConceptScore W2007657956C153911025 @default.
- W2007657956 hasConceptScore W2007657956C154317977 @default.
- W2007657956 hasConceptScore W2007657956C159654299 @default.
- W2007657956 hasConceptScore W2007657956C178790620 @default.
- W2007657956 hasConceptScore W2007657956C181199279 @default.
- W2007657956 hasConceptScore W2007657956C185592680 @default.
- W2007657956 hasConceptScore W2007657956C202751555 @default.
- W2007657956 hasConceptScore W2007657956C203014093 @default.
- W2007657956 hasConceptScore W2007657956C2777318727 @default.
- W2007657956 hasConceptScore W2007657956C2779491297 @default.
- W2007657956 hasConceptScore W2007657956C2780783641 @default.
- W2007657956 hasConceptScore W2007657956C29730261 @default.
- W2007657956 hasConceptScore W2007657956C542903549 @default.
- W2007657956 hasConceptScore W2007657956C55493867 @default.
- W2007657956 hasConceptScore W2007657956C86803240 @default.
- W2007657956 hasConceptScore W2007657956C98274493 @default.
- W2007657956 hasIssue "3" @default.
- W2007657956 hasLocation W20076579561 @default.
- W2007657956 hasOpenAccess W2007657956 @default.
- W2007657956 hasPrimaryLocation W20076579561 @default.
- W2007657956 hasRelatedWork W1971852928 @default.
- W2007657956 hasRelatedWork W1990434843 @default.
- W2007657956 hasRelatedWork W1994966299 @default.
- W2007657956 hasRelatedWork W2058298091 @default.
- W2007657956 hasRelatedWork W2072754176 @default.
- W2007657956 hasRelatedWork W2094784840 @default.
- W2007657956 hasRelatedWork W2286331521 @default.
- W2007657956 hasRelatedWork W2368460920 @default.
- W2007657956 hasRelatedWork W2380360044 @default.
- W2007657956 hasRelatedWork W2443772760 @default.
- W2007657956 hasVolume "123" @default.
- W2007657956 isParatext "false" @default.
- W2007657956 isRetracted "false" @default.
- W2007657956 magId "2007657956" @default.
- W2007657956 workType "article" @default.